Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Wei Teng; Ting-Tsung Chang; Hwai-I Yang; Cheng-Yuan Peng; Chien-Wei Su; Tung-Hung Su; Tsung-Hui Hu; Ming-Lung Yu; Hung-Chih Yang; Jaw-Ching Wu

doi:10.1007/s12072-023-10634-6

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Hepatol Int. 2024 Jan 22. doi: 10.1007/s12072-023-10634-6. Online ahead of print.

Authors

Wei Teng^{1

2}, Ting-Tsung Chang³, Hwai-I Yang⁴, Cheng-Yuan Peng⁵, Chien-Wei Su⁶, Tung-Hung Su⁷, Tsung-Hui Hu⁸, Ming-Lung Yu⁹, Hung-Chih Yang⁷, Jaw-Ching Wu^{10

11

12}

Affiliations

¹ Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China.
² Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan, Republic of China.
³ Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China.
⁴ Genomics Research Center, Academia Sinica, Taipei, Taiwan, Republic of China.
⁵ Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Republic of China.
⁶ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
⁷ Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
⁸ Department of Gastroenterology and Hepatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China.
⁹ Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China.
¹⁰ Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China. penfieldwu@gmail.com.
¹¹ Translational Research Division, Medical Research Department, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China. penfieldwu@gmail.com.
¹² Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China. penfieldwu@gmail.com.

PMID: 38252366
DOI: 10.1007/s12072-023-10634-6

No abstract available

Publication types

Published Erratum